Cycloepoxydon, 1-hydroxy-2-hydroxymethyl-3-pent-1-enylbenzene and 1-hydroxy-2-hydroxymethyl-3-pent-1,3-dienylbenzene, new inhibitors of eukaryotic signal transduction

Journal of Antibiotics

Volumn 51, Issue 5, 1998, Pages 455-463

  Gehrt, Alexandra ^a   Erkel, Gerhard ^a   Anke, Timm ^a   Sterner, Olov ^b  

^a Rheinland Pfälzische Technische Universität Kaiserslautern Landau   (Germany)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

1 HYDROXY 2 HYDROXYMETHYL 3 PENT 1 ENYLBENZENE; 1 HYDROXY 2 HYDROXYMETHYL 3 PENT 1,3 DIENYLBENZENE; ALKALINE PHOSPHATASE; BENZENE DERIVATIVE; CYCLOEPOXYDON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONSENSUS SEQUENCE; CONTROLLED STUDY; DEUTEROMYCETES; DRUG ISOLATION; ELECTROPHORETIC MOBILITY; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REPORTER GENE; SIGNAL TRANSDUCTION;

EID: 0031782069     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.51.455     Document Type: Article

References (27)

1. BAEUERLE, P. A. & T. HENKEL: Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12: 141-179, 1994
2. BALDWIN, A. S.: The NF-κB and IκB Proteins: New Discoveries and Insights. Annu. Rev. Immunol. 14: 649-681, 1996
3. DIDONATO, J. A.; M. HAYAKAWA, D. ROTHWARF, E. ZNADI & M. KARIN: A cytokine- responsive IκB kinase that activates the transcription factor NF-κB. Nature 388: 548-554, 1997
4. RÉGNIER, C. H.; H. Y. SONG, X. GAO, D. V. GOEDDEL, Z. CAO & M. ROTHE: Identification and characterization of an IκB kinase. Cell 90: 373-383, 1997
5. DIDONATO, J. A.; F. MERCURIO, C. ROSETTE, J. WU-LI, H. SUYANG, S. GHOSH & M. KARIN: Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell Biol. 16: 1295-1304, 1996
6. MANNING, A. M. & D. C. ANDERSON: Transcription Factor NF-κB: An Emerging Regulator of Inflammation. Annu. Rep. Med. Chem. 29: 235-244, 1994
7. BARNES, P. J. & I. M. ADCOCK: NF-κB: a pivotal role in asthma and a new target for therapy. TiPS 18: 46-50, 1997
8. STEIN, B.; A. S. BALDWIN, D. W. BALLARD, W. C. GREENE, P. ANGEL & P. HERRLICH: Cross-coupling of the NF-κB p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J. 12: 3879-3891, 1993
9. ANGEL, P. & M. KARIN: The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072: 129-157, 1991
10. GEHRT, A.; G. ERKEL, H. ANKE, T. ANKE & O. STERNER: New Hexaketide Inhibitors of Eukaryotic Signal Transduction. Natl. Prod. Lett. 9: 259-264, 1997
11. ANKE, H.; O. BERGENDORFF & O. STERNER: Assays of the biological activities of guaiane sesquiterpenoids isolated from the fruit bodies of edible Lactarius species. Food Chem. Toxicol. 27: 393-398, 1989
12. ZAPF. S.; M. HOBFELD, H. ANKE, R. VELTEN & W. STEGLICH: Darlucins A and B, new isocyanide antibiotics from Sphaerellopsis filum (Darluca filum). J. Antibiotics 48: 36-41, 1993
13. WEBER, W.; T. ANKE, B. STEFAN & W. STEGLICH: Antibiotics from basidiomycetes. XXXII. Strobilurin E: A new cytostatic and antifungal E-β-methoxyacrylate antibiotic from Crepidotus fulvotomentosus Peck. J. Antibiotics 43: 207-212, 1990
14. VENITT, S.; C. CROFTON-SLEIGHT & R. FORSTER: Mutagenicity Testing a Practical Approach. IRL Press, Oxford, New York, pp. 45-98, 1984
15. ERKEL, G.; T. ANKE & O. STERNER: Inhibition of NF-κB Activation by Panepoxydone. Biochem. Biophys. Res. Commun. 226: 214-221, 1996
16. PAHL, H. L. & P. A. BAEUERLE: A novel signal transduction pathway from the endoplasmatic reticulum to the nucleus is mediated by transcription factor NF-κB. EMBO J. 14: 2580-2588, 1995
17. TRAENCKNER, E. B.-M.; S. WILK & P. A. BAEUERLE: A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκB-α that is still bound to NF-κB. EMBO J. 13: 5433-5441, 1994
18. DIDONATO, J. A.; F. MERCURIO & M. KARIN: Phosphorylation of IκB-α preceeds but is not sufficient for its dissociation from NF-κB. Mol. Cell Biol. 15: 1302-1311, 1995
19. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 12: 2005-2015, 1993
20. PAHL, H. L.; B. KRAUß, K. SCHULZE-OSTHOFF, T. DECKER, E. B.-M. TRAENCKNER, M. VOGT, C. MYERS, T. PARKS, P. WARRING, A. MÜHLBACHER, A.- P. CZERNILOFSKY & P. A. BAEUERLE: The immunosuppressive fungal Metabolite Gliotoxin specifically inhibits transcription factor NF-κB. J. Exp. Med. 183: 1829-1840, 1996
21. KARIN, M.: The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270: 16483-16486, 1995
22. MINDEN, A. & M. KARIN: Regulation and function of the JNK subgroup of MAP kinases. Biochim. Biophys. Acta 1333: F85-F104, 1997
23. KYRIAKIS, J. M. & J. AVRUCH: Sounding the alarm: protein kinase cascades activated by stress and inflammation. J. Biol. Chem. 271: 24313-24316, 1996
24. 2-terminal kinase) is a target for antioxidants in T lymphocytes. J. Biol. Chem. 271: 26335-26340, 1996
25. WESSELBORG, S.; M. K. A. BAUER, M. VOGT, M. LIENHARD SCHMITZ & K. SCHULZE-OSTHOFF: Activation of transcription factor NF-κB and p38 mitogen-activated protein kinase is mediated by distinct and separate stress effector pathways. J. Biol. Chem. 272: 12422-12429, 1997
26. GÖTTLICHER, M.; H. J. RAHMSDORF & P. HERRLICH: The AP-1 family of transcription factors: Multi-level control of activity. In Transcription factors in Eukaryotes. Ed., A. PAPAVASSILIOU, R. G. LANDES, MBIU book series, in press
27. EL-SHEMERLY, M. Y. M.; D. BESSER, M. NAGASAWA & Y. NAGAMINE: 12-O-tetradecanoylphorbol-13-acetate activates the RAS/Extracellular signal-regulated kinase (ERK) signalling pathway upstream of SOS involving serine phosphorylation of Shc in NIH3T3 cells. J. Biol. Chem. 272: 30599-30602, 1997